All In Biotech

Drug Trial Radar · NCT07782333

A Study Evaluating TRIV-573 in Atopic Dermatitis

A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-573 in Participants With Moderate to Severe Atopic Dermatitis

Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Sep 9, 2026

Primary completion

Aug 2027

Study completion Feb 2028

Sponsor

Lead sponsor
Triveni BioIndustry
Sponsor type
Industry
First posted
Aug 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo). The study duration for individual participants is up to 40 weeks, including a Screening period of up to 30 days.

Conditions

  • Atopic Dermatitis

Interventions

  • TRIV-573Drug

    TRIV-573 (Subcutaneous injection)

  • PlaceboDrug

    Placebo (Matching Placebo subcutaneous injection)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants with improvement of ADTime frame: Baseline through Week 16

Locations

17 sites in 3 countries. Site status is shown where the registry gives one.

  • Triveni Bio Site #15

    Fountain Valley, California · Recruiting

  • Triveni Bio Site #4

    Los Angeles, California · Recruiting

  • Triveni Bio Site #11

    Boca Raton, Florida · Recruiting

  • Triveni Bio Site #7

    Miami, Florida · Recruiting

  • Triveni Bio Site #3

    Miami, Florida · Recruiting

  • Triveni Bio Site #2

    Indianapolis, Indiana · Recruiting

  • Triveni Bio Site #13

    Bay City, Michigan · Recruiting

  • Triveni Bio Site #16

    Boardman, Ohio · Recruiting

  • Triveni Bio Site #1

    Camp Hill, Pennsylvania · Recruiting

  • Triveni Bio Site #14

    Myrtle Beach, South Carolina · Recruiting

  • Triveni Bio Site #9

    San Antonio, Texas · Recruiting

  • Triveni Bio Site #6

    San Antonio, Texas · Recruiting

  • Triveni Bio Site #8

    Spokane, Washington · Recruiting

  • Triveni Bio Site #17

    Calgary, Alberta, Canada · Recruiting

  • Triveni Bio Site #5

    Barrie, Ontario, Canada · Recruiting

  • Triveni Bio Site #12

    Ivano-Frankivsk, Ukraine · Recruiting

  • Triveni Bio Site #10

    Kyiv, Ukraine · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.